{
  "id": "90e474018ff97310",
  "title": "OS Therapies : OS Therapies Provides Global Regulatory Update for OST - HER2 in Recurrent , Fully Resected , Pulmonary Metstatic Osteosarcoma",
  "description": "20260217T113000Z",
  "content": "",
  "source": "finanznachrichten.de",
  "source_url": "https://www.finanznachrichten.de/nachrichten-2026-02/67717555-os-therapies-os-therapies-provides-global-regulatory-update-for-ost-her2-in-recurrent-fully-resected-pulmonary-metstatic-osteosarcoma-296.htm",
  "published_at": "20260217T113000Z",
  "fetched_at": "2026-02-18T00:30:07.542614+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "regulatory"
  ],
  "location": "Germany",
  "raw_data": {
    "url": "https://www.finanznachrichten.de/nachrichten-2026-02/67717555-os-therapies-os-therapies-provides-global-regulatory-update-for-ost-her2-in-recurrent-fully-resected-pulmonary-metstatic-osteosarcoma-296.htm",
    "url_mobile": "",
    "title": "OS Therapies : OS Therapies Provides Global Regulatory Update for OST - HER2 in Recurrent , Fully Resected , Pulmonary Metstatic Osteosarcoma",
    "seendate": "20260217T113000Z",
    "socialimage": "",
    "domain": "finanznachrichten.de",
    "language": "English",
    "sourcecountry": "Germany"
  }
}